如何利用药物使用评估来实现抗菌药物管理目标:一本医生入门书
Ritika Prasad1,2, Radhika Arya1,2, Lina Meng1,2
1Division of Infectious Diseases and Geographic Medicine, Stanford University School of Medicine, Stanford, CA, USA.
Antimicrobial stewardship & healthcare epidemiology : ASHE
|October 23, 2025
概括
药物使用评估 (MUE) 为抗菌药物管理计划 (ASP) 提供了质量改进的机会. 本指南有助于管理医生领导MUE,增强抗菌药物管理和跨学科合作.
科学领域:
- 医疗保健服务研究 医疗服务研究
- 提高质量 提高科学 提高质量
- 传染性疾病 传染性疾病
背景情况:
- 药物使用评估 (MUE) 是优化医疗保健中药物使用的结构化工具.
- 这些MUE解决了药物的安全性,成本和适当性问题,与抗微生物药物管理计划 (ASP) 的目标保持一致.
- 虽然药剂师经常领导MUE,但医生可能缺乏这种质量改善过程的经验.
研究的目的:
- 为管理医生提供指导,帮助他们有效地参与MUE过程.
- 让医生有能力为MUE做出贡献,即使没有先前的经验.
- 突出MUE在促进抗菌药物管理和跨学科合作方面的作用.
主要方法:
- 基于MUE过程制定指导方针.
- 专注于医生从主题识别到实施支持的参与.
- 重点是利用MUE来管理和培训人员发展.
主要成果:
- 医生可以通过遵循结构化的指导来有效地领导或为MUEs做出贡献.
- MUE为医生提供了一个平台,以解决与抗微生物药物相关的问题,并促进管理.
- 该过程促进了跨学科的合作,并为学员提供了领导机会.
结论:
- 管理医生可以对MUEs做出重大贡献,提高药物安全性和抗菌药物管理.
- 在医疗保健系统中,MUE是医生推动质量改善举措的宝贵工具.
- 本指南旨在弥合培训差距,并促进医生参与MUE.
相关概念视频
Antimicrobial Effectiveness
898
The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
898
Combined Effects of Drugs: Synergism
6.7K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
6.7K
Healthcare Associated Infections II: Preventive Measures
3.6K
Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
3.6K
Drug Dosing: Geriatric Patients
222
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
222
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
1.1K
Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
1.1K
Therapeutic Drug Monitoring: Affecting Factors
200
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
200


